Bruker Gross Margin from 2010 to 2024

BRKR Stock  USD 78.56  4.38  5.28%   
Check Bruker financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bruker main balance sheet or income statement drivers, such as Interest Expense of 12.1 M, Total Revenue of 3.1 B or Gross Profit of 1.6 B, as well as many exotic indicators such as Price To Sales Ratio of 5.18, Dividend Yield of 0.0026 or PTB Ratio of 14.38. Bruker financial statements analysis is a perfect complement when working with Bruker Valuation or Volatility modules.
  
This module can also supplement Bruker's financial leverage analysis and stock options assessment as well as various Bruker Technical models . Check out the analysis of Bruker Correlation against competitors.
To learn how to invest in Bruker Stock, please use our How to Invest in Bruker guide.

About Bruker Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Bruker income statement, its balance sheet, and the statement of cash flows. Bruker investors use historical funamental indicators, such as Bruker's Gross Margin, to determine how well the company is positioned to perform in the future. Although Bruker investors may use each financial statement separately, they are all related. The changes in Bruker's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Bruker's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Bruker Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Bruker. Please read more on our technical analysis and fundamental analysis pages.
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts. Bruker Corp operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 7765 people.

Pair Trading with Bruker

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bruker position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bruker will appreciate offsetting losses from the drop in the long position's value.

Moving together with Bruker Stock

  0.91A Agilent Technologies Financial Report 28th of May 2024 PairCorr
  0.83EQ Equillium Financial Report 9th of May 2024 PairCorr
  0.64YS YS Biopharma Report 22nd of April 2024 PairCorr

Moving against Bruker Stock

  0.89KA Kineta Inc Financial Report 9th of May 2024 PairCorr
  0.83DMTK DermTech Financial Report 2nd of May 2024 PairCorr
  0.81VCYT Veracyte Financial Report 2nd of May 2024 PairCorr
  0.8ME 23Andme HoldingPairCorr
  0.56VALN Valneva SE ADR Financial Report 2nd of May 2024 PairCorr
The ability to find closely correlated positions to Bruker could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bruker when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bruker - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bruker to buy it.
The correlation of Bruker is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bruker moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bruker moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bruker can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Bruker is a strong investment it is important to analyze Bruker's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Bruker's future performance. For an informed investment choice regarding Bruker Stock, refer to the following important reports:
Check out the analysis of Bruker Correlation against competitors.
To learn how to invest in Bruker Stock, please use our How to Invest in Bruker guide.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Complementary Tools for Bruker Stock analysis

When running Bruker's price analysis, check to measure Bruker's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bruker is operating at the current time. Most of Bruker's value examination focuses on studying past and present price action to predict the probability of Bruker's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bruker's price. Additionally, you may evaluate how the addition of Bruker to your portfolios can decrease your overall portfolio volatility.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Is Bruker's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bruker. If investors know Bruker will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bruker listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.127
Dividend Share
0.2
Earnings Share
2.9
Revenue Per Share
20.249
Quarterly Revenue Growth
0.206
The market value of Bruker is measured differently than its book value, which is the value of Bruker that is recorded on the company's balance sheet. Investors also form their own opinion of Bruker's value that differs from its market value or its book value, called intrinsic value, which is Bruker's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bruker's market value can be influenced by many factors that don't directly affect Bruker's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bruker's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bruker is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bruker's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.